Show simple item record

dc.contributor.authorYurtcu, N
dc.contributor.authorCetin, A
dc.contributor.authorKaradas, B
dc.contributor.authorImir, AG
dc.contributor.authorKaya, T
dc.contributor.authorErselcan, T
dc.contributor.authorBagcivan, I
dc.contributor.authorCetin, M
dc.date.accessioned2019-07-27T12:10:23Z
dc.date.accessioned2019-07-28T10:21:53Z
dc.date.available2019-07-27T12:10:23Z
dc.date.available2019-07-28T10:21:53Z
dc.date.issued2006
dc.identifier.issn0014-2999
dc.identifier.issn1879-0712
dc.identifier.urihttps://dx.doi.org/10.1016/j.ejphar.2005.11.018
dc.identifier.urihttps://hdl.handle.net/20.500.12418/10879
dc.descriptionWOS: 000235343900010en_US
dc.descriptionPubMed ID: 16388799en_US
dc.description.abstractThis study was designed to compare the effects of beta-adrenoccptoy agonists formoterol and BRL 37344 on spontaneous contractions and the levels of cAMP and cGMP of myometrial strips isolated from timed-pregnant rats. Myometrial strips were obtained from term-pregnant Wistar albino rats (n = 12), mounted in organ baths and tested for changes in isometric tension in response to formoterol and BRL 37344. We evaluated the effect of increasing concentrations of formoterol and BRL 37344 on oxytocin-induced myometrial contractions and on contractions of myometrial smooth muscle pretreated with metoprolol, ICI 118.551 and SR 59230A (beta(1), beta(2), beta(3)-adrenoceptor antagonist, respectively, 10-6 M). Effects of formoterol and BRL 37344 on cAMP and cGMP levels in isolated myornetrial strips (n=6) were evaluated by radio immunoassay kits. Formoterol (10(-12) - 10(-8) M) and BRL 37344 (10(-11)-10(-5) M) concentration-dependently decreased the amplitude of oxytocin-induced contractions. E-max value (100%) of formoterol was increased significantly more than E-max value (70.6%) of BRL 37344 (P < 0.05), with no change in pD(2) value (9.54 +/- 0.12 and 9.12 +/- 0.12, respectively). The inhibition of the amplitude of oxytocin-induced contractions by formoterol was antagonized with ICI 118.551 (10(-6) M), but they were not changed by nictoprolol (10(-6) M) or SR 59230A (10(-6) M). The inhibition of the amplitude of oxytocin-induced contractions by BRL 37344 were antagonized with SR 59230A (10(-6) M), but they were not changed by metoprolol (10(-6) M) or ICT 118.551 (10(-6) M). Formoterol and BRL 37344 increased cAMP levels. BRL 37344 increased cGMP levels in BRL 37344 group more than control group, but this increase is less significant than cAMP levels (P > 0.05). Fon-noterol and BRL 37344 decreased amplitude of myometrial contractions with similar potency, but efficacy of forinoterol was better than BRL 37344. (c) 2005 Elsevier B.V. All rights reserved.en_US
dc.language.isoengen_US
dc.publisherELSEVIER SCIENCE BVen_US
dc.relation.isversionof10.1016/j.ejphar.2005.11.018en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectformoterolen_US
dc.subjectBRL 37344en_US
dc.subjectpreterm laboren_US
dc.subjectcAMPen_US
dc.subjectcGMPen_US
dc.subject(rat)en_US
dc.titleComparison of effects of formoterol and BRL 37344 on isolated term-pregnant rat myometrial strips in vitroen_US
dc.typearticleen_US
dc.relation.journalEUROPEAN JOURNAL OF PHARMACOLOGYen_US
dc.contributor.departmentCumhuriyet Univ, Sch Med, Dept Obstet & Gynecol, TR-58140 Sivas, Turkey -- Cumhuriyet Univ, Sch Med, Dept Pharmacol, TR-58140 Sivas, Turkey -- Cumhuriyet Univ, Sch Med, Dept Nucl Med, TR-58140 Sivas, Turkeyen_US
dc.contributor.authorIDCetin, Ali -- 0000-0002-5767-7894en_US
dc.identifier.volume530en_US
dc.identifier.issue3en_US
dc.identifier.endpage269en_US
dc.identifier.startpage263en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record